SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Uygur, Berna ^a,b   Wu, Wen Shu ^b,c  

^a UNIVERSITY OF MAINE   (United States)

^b Maine Medical Center Research Institute   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR SLUG; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LENTIVIRINAE; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 80755143039     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-139     Document Type: Article

References (46)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Liu J, Uygur B, Zhang Z, Shao L, Romero D, Vary C, Ding Q, Wu WS. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression. Prostate 2010, 70:1768-1777.
3. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002, 3:155-166.
4. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89. 10.1038/35000034, 10655587.
5. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009, 15:195-206. 10.1016/j.ccr.2009.01.023, 19249678.
6. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383. 10.1002/jcp.21223, 17680632.
7. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62:1613-1618.
8. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005, 12:488-496. 10.1245/ASO.2005.04.010, 15864483.
9. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attractB lymphoma cells via production ofstromal cell derived factor 1. European Journal of Haematology 2000, 64:323-332. 10.1034/j.1600-0609.2000.90147.x, 10863978.
10. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annual review of immunology 2000, 18:217-242. 10.1146/annurev.immunol.18.1.217, 10837058.
11. Begley LA, MacDonald JW, Day ML, Macoska JA. CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J Biol Chem 2007, 282:26767-26774. 10.1074/jbc.M700440200, 17631494.
12. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004, 64:8420-8427. 10.1158/0008-5472.CAN-04-1343, 15548713.
13. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9448. 10.1073/pnas.95.16.9448, 21358, 9689100.
14. Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer 2004, 4:540-550. 10.1038/nrc1388, 15229479.
15. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008, 48:171-197. 10.1146/annurev.pharmtox.48.121806.154841, 17883327.
16. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clinical Cancer Research 2010, 16:2927. 10.1158/1078-0432.CCR-09-2329, 20484021.
17. Eisenhardt A, Frey U, Tack M, Rosskopf D, Lummen G, Rubben H, Siffert W. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol 2005, 47:111-117. 10.1016/j.eururo.2004.10.001, 15582259.
18. Cabioglu N, Sahin AA, Morandi P, Meric-Bernstam F, Islam R, Lin HY, Bucana CD, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M. Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications. Ann Oncol 2009, 20:1013-1019. 10.1093/annonc/mdn740, 19237480.
19. Tan CT, Chu CY, Lu YC, Chang CC, Lin BR, Wu HH, Liu HL, Cha ST, Prakash E, Ko JY. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis 2008, 29:1519. 10.1093/carcin/bgn108, 18487224.
20. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002, 62:5930-5938.
21. Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. Stromal Derived Factor-1(SDF-1/CXCL 12) and CXCR 4 in renal cell carcinoma metastasis. Molecular cancer 2006, 5:56. 10.1186/1476-4598-5-56, 1636662, 17083723.
22. Chinni SR, Yamamoto H, Dong Z, Sabbota A, Bonfil RD, Cher ML. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol Cancer Res 2008, 6:446-457. 10.1158/1541-7786.MCR-07-0117, 18337451.
23. Gladson CL, Welch DR. New insights into the role of CXCR4 in prostate cancer metastasis. Cancer biology & therapy 2008, 7:1849. 10.4161/cbt.7.11.7218, 22081335.
24. Piva R, Manferdini C, Lambertini E, Torreggiani E, Penolazzi L, Gambari R, Pastore A, Pelucchi S, Gabusi E, Piacentini A. Slug contributes to the regulation of CXCL12 expression in human osteoblasts. Experimental Cell Research 2010, 317:1159-1168.
25. Zhang K, Chen D, Jiao X, Zhang S, Liu X, Cao J, Wu L, Wang D. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Laboratory Investigation 2011, 91:426-438. 10.1038/labinvest.2010.201, 3125102, 21283078.
26. Shanmugam MK, Manu KA, Ong TH, Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM, Sethi G. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer 2011, 129:1552-1563. 10.1002/ijc.26120, 21480220.
27. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003, 89:462-473. 10.1002/jcb.10522, 12761880.
28. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002, 62:1832-1837.
29. Tandon A, Sinha S. Structural insights into the binding of MMP9 inhibitors. Bioinformation 5:310-314.
30. Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML. CXCL12/CXCR4 signaling activates Akt-1 and MMP9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 2006, 66:32-48. 10.1002/pros.20318, 16114056.
31. Camp ER, Findlay VJ, Vaena SG, Walsh J, Lewin DN, Turner DP, Watson DK. Slug Expression Enhances Tumor Formation in a Noninvasive Rectal Cancer Model. J Surg Res 2011, 170:56-63. 10.1016/j.jss.2011.02.012, 21470622.
32. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer research 2005, 65:5864. 10.1158/0008-5472.CAN-04-3833, 15994964.
33. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E, Peled A. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004, 18:1240-1242.
34. Arya M, Patel H, McGURK C, Tatoud R, Klocker H, Masters J, Williamson M. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. Journal of experimental therapeutics & oncology 2004, 4:291.
35. Xing Y, Liu M, Du Y, Qu F, Li Y, Zhang Q, Xiao Y, Zhao J, Zeng F, Xiao C. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach. Cancer biology & therapy 2008, 7:1839. 10.4161/cbt.7.11.6862, 22081335.
36. Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol 2009, 23:1385-1396. 10.1210/me.2009-0010, 2737557, 19460858.
37. Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B. MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One 5:e14304.
38. Chu C, Cha S, Chang C, Hsiao C, Tan C, Lu Y, Jee S, Kuo M. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 -directed invasion of human basal cell carcinoma cells. Oncogene 2006, 26:2491-2501.
39. Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. Up-regulation of CXCR4 Expression in PC3 Cells by Stromal-Derived Factor-1 (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway-Dependent NF- B Activation. Cancer research 2005, 65:9891. 10.1158/0008-5472.CAN-05-1293, 16267013.
40. Thieme S, Ryser M, Gentsch M, Navratiel K, Brenner S, Stiehler M, Rolfing J, Gelinsky M, Rosen-Wolff A. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds. Tissue Eng Part C Methods 2009, 15:687-696. 10.1089/ten.tec.2008.0556, 19260802.
41. Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102:815-827.
42. Zhang K, Zhang S, Jiao X, Wang H, Zhang D, Niu Z, Shen Y, Lv L, Zhou Y. Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo. Med Oncol 2010,
43. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 71:245-254.
44. Shen X, Wang S, Wang H, Liang M, Xiao L, Wang Z. The role of SDF-1/CXCR4 axis in ovarian cancer metastasis. Journal of Huazhong University of Science and Technology--Medical Sciences-- 2009, 29:363-367.
45. Towler D. Cancer Interaction with the Bone Microenvironment. American Journal of Pathology 2006, 168.
46. Patrussi L, Baldari CT. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection. Curr Med Chem 18:497-512.